Variability of Respiratory Symptoms in Severe COPD;Variabilidad de los síntomas respiratorios en la EPOC grave

Archivos de Bronconeumologia

Volumn 48, Issue 1, 2012, Pages 3-7

  Espinosa de los Monteros, María José ^a   Peña, Carolina ^b   Soto Hurtado, Enrique Javier ^c   Jareño, Javier ^d   Miravitlles, Marc ^e  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b ASTRAZENECA   (United Kingdom)

^c Hospital de la Serrania   (Spain)

^d HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Activity; Chronic obstructive pulmonary disease (COPD); Dyspnea; Symptoms

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME VARIABLE; SYMPTOM; ADULT; AUSTRIA; BELGIUM; COHORT ANALYSIS; DENMARK; DISEASE COURSE; FAMILY COUNSELING; FINLAND; FRANCE; GENERAL PRACTITIONER; GERMANY; GREECE; IRELAND; ITALY; MIDDLE AGED; NETHERLANDS; NORWAY; OBSERVATIONAL STUDY; PERCEPTION; PORTUGAL; PULMONOLOGIST; SPANIARD; SWEDEN; SWITZERLAND; TELEPHONE INTERVIEW; TURKEY (REPUBLIC); UNITED KINGDOM;

AGED; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; COHORT STUDIES; COUGH; CROSS-SECTIONAL STUDIES; DYSPNEA; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RESPIRATORY SOUNDS; SLEEP DISORDERS, INTRINSIC; SPAIN; TELEPHONE;

EID: 84855825457     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2011.07.004     Document Type: Article

References (18)

1. Clark T.J. Diurnal rhythm of asthma. Chest 1987, 91:137S-141S.
2. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
3. Haughney J., Partridge M.R., Vogelmeier C., Larsson T., Kessler R., Stahl E., et al. Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling. Eur Respir J 2005, 26:623-629.
4. Gibson P.G., Simpson J.L. The overlap syndrome of asthma and COPD: what are its features and how important is it?. Thorax 2009, 64:728-735.
5. Kessler R., Partridge M.R., Miravitlles M., Cazzola M., Vogelmeier C., Leynaud D., et al. Symptom variability in patients with severe COPD - a pan-European cross-sectional study. Eur Respir J 2011, 37:264-272.
6. Miravitlles M., Murio C., Tirado-Conde G., Levy G., Muellerova H., Soriano J.B., et al. Geographic differences in clinical characteristics and management of COPD: The EPOCA study. Int J Chron Obstruc Pulmon Dis 2008, 3:803-814.
7. Miravitlles M., Anzueto A., Ewig S., Legnani D., Stauch K. Characterization of exacerbations of chronic bronchitis and COPD in Europe. The GIANT study. Ther Adv Respir Dis 2009, 3:267-277.
8. Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54:581-586.
9. Menezes A.M.B., Perez-Padilla R., Jardim J.R.B., Muiño A., Lopez M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet 2005, 366:1875-1881.
10. Sobradillo V., Miravitlles M., Gabriel R., Jiménez-Ruiz C.A., Villasante C., Masa J.F., et al. Geographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study. Chest 2000, 118:981-989.
11. Miravitlles M., Soriano J.B., García-Río F., Muñoz L., Duran-Taulería E., Sánchez G., et al. Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009, 64:863-868.
12. Garcia-Aymerich J., Lange P., Benet M., Schnohr P., Antó J.M. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006, 61:772-778.
13. Esteban C., Quintana J.M., Aburto M., Moraza J., Egurrola M., Pérez-Izquierdo J., et al. Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010, 36:292-300.
14. Calverley P.M., Lee A., Towse L., van Noord J., Witek T.J., Kelsen S. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003, 58:855-860.
15. Partridge M.R., Karlsson N., Small I.R. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: An internet survey. Curr Med Res Opin 2009, 25:2043-2048.
16. Partridge M.R., Miravitlles M., Stahl E., Karlsson N., Svensson K., Welte T. Development and validation of the capacity of daily living during the morning and global chest symptoms questionnaires in COPD. Eur Respir J 2010, 36:96-104.
17. Naberan K., de la Roza C., Lamban M., Gobartt E., Martín A., Miravitlles M. Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in Primary Care. Arch Bronconeumol 2006, 42:638-644.
18. Monteagudo M., Rodriguez-Blanco T., Parcet J., Peñalver N., Rubio C., Ferrer M., et al. Variabilidad en la realización de la espirometría y sus consecuencias en el tratamiento de la EPOC en Atención Primaria. Arch Bronconeumol 2011, 47:226-233.